Thioridazine: re-evaluating the risk/benefit equation

AM Timell - Annals of clinical psychiatry, 2000 - Taylor & Francis
The piperidine phenothiazine thioridazine has been in use for 40 years. As clinical
experience has accumulated, scattered reports of sudden death and fatal or nonfatal …

Inhibition of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine

GP Zaloga, JD Clark, PR Roberts - Critical care medicine, 2000 - journals.lww.com
Inhibition of nitric oxide synthase enhances the myocardial... : Critical Care Medicine Inhibition
of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine : Critical …